CIK 0001861123 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Eikon Therapeutics, Inc.
Sign in to watch- Ticker
- EIKN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 842807586
- Phone
- 341-777-0566
- Business address
- 230 HARRIET TUBMAN WAY, MILLBRAE, CA, 94030
- Open-market buys, last 90 days
- $1,031,045
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$1,031,045. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-03 | Column Group IV GP, LP 10% owner | Purchase | +89,200 | $11.56 | $1.0M | 89,200 |
| 2026-02-06 | Column Group IV GP, LP 10% owner | Purchase | +1,437,323 | $18.00 | $25.9M | 4,312,139 |
| 2026-02-06 | Column Group IV GP, LP 10% owner | Purchase | +49,556 | $18.00 | $892K | 148,840 |
| 2026-02-06 | Column Group IV GP, LP 10% owner | Purchase | +630,881 | $18.00 | $11.4M | 1,319,164 |
| 2026-02-04 | FRAZIER KENNETH C Director | Purchase | +111,111 | $18.00 | $2.0M | 111,111 |
| 2026-02-04 | Wolfe Josh Director | Purchase | +138,888 | $18.00 | $2.5M | 138,888 |
| 2026-02-04 | Wolfe Josh Director | Purchase | +138,888 | $18.00 | $2.5M | 138,888 |
| 2026-02-04 | Lux Venture Partners V, LLC 10% owner | Purchase | +138,888 | $18.00 | $2.5M | 138,888 |
| 2026-02-04 | Lux Venture Partners V, LLC 10% owner | Purchase | +138,888 | $18.00 | $2.5M | 138,888 |
| 2026-02-04 | Foresite Capital Management IV, LLC 10% owner | Purchase | +55,555 | $18.00 | $1000K | 1,318,983 |
Page 1 of 1 · 10 trades